Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
DMAA Stock Chart & Stats
$10.53
--
Market closed
$10.53
--
Day’s Range― - ―
52-Week Range$10.17 - $10.62
Previous CloseN/A
VolumeN/A
Average Volume (3M)49.15K
Market Cap
$257.70M
Enterprise Value$357.82M
Total Cash (Recent Filing)$14.89K
Total Debt (Recent Filing)$100.00K
Price to Earnings (P/E)36.7
Beta<0.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.21
Shares Outstanding24,276,913
10 Day Avg. Volume49,577
30 Day Avg. Volume49,150
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)0.94
Price to Sales (P/S)0.00
P/FCF Ratio-404.04
Enterprise Value/Market Cap1.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-136.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Drugs Made In America Acquisition Corp. News
DMAA FAQ
What was Drugs Made In America Acquisition Corp.’s price range in the past 12 months?
Drugs Made In America Acquisition Corp. lowest stock price was $10.17 and its highest was $10.62 in the past 12 months.
What is Drugs Made In America Acquisition Corp.’s market cap?
Drugs Made In America Acquisition Corp.’s market cap is $257.70M.
When is Drugs Made In America Acquisition Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Drugs Made In America Acquisition Corp.’s earnings last quarter?
Currently, no data Available
Is Drugs Made In America Acquisition Corp. overvalued?
According to Wall Street analysts Drugs Made In America Acquisition Corp.’s price is currently Overvalued.
Does Drugs Made In America Acquisition Corp. pay dividends?
Drugs Made In America Acquisition Corp. does not currently pay dividends.
What is Drugs Made In America Acquisition Corp.’s EPS estimate?
Drugs Made In America Acquisition Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Drugs Made In America Acquisition Corp. have?
Drugs Made In America Acquisition Corp. has 24,276,913 shares outstanding.
What happened to Drugs Made In America Acquisition Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Drugs Made In America Acquisition Corp.?
Currently, no hedge funds are holding shares in DMAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Drugs Made In America Acquisition Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
3.90%
Trailing 12-Months
Asset Growth
3.58%
Trailing 12-Months
Company Description
Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations.
Technical Analysis
Bolt Projects Holdings
―
―
Four Leaf Acquisition Corporation Class A
―
Bayview Acquisition Corp Class A
―
―
Ownership Overview
―
Insiders
10.73% Mutual Funds
61.28% Other Institutional Investors
27.89% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---